Dapagliflozin associated with improved outcomes in heart failure patients regardless of frailty - Medical Dialogues
4/25/2022 12:00:00 AM3 yearsago
by Dr. Kamal Kant Kohli
by Dr. Kamal Kant Kohli
A post-hoc analysis of the DAPA-HF (Dapagliflozin and Prevention of Adverse Outcomes in Heart...
A post-hoc analysis of the DAPA-HF (Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure) randomized control trial found that dapagliflozin improved outcomes in heart failure patients re… [+1675 chars]
full article...